Edell Michael purchased $1K of SNES
Edell Michael (Chief Executive Officer) purchased 2,000 shares of SenesTech, Inc. (SNES) at $0.64 on 2026-09-28.
How this was made
The 30-second read
Why it matters
The CEO's modest buy may provide a slight confidence boost but is unlikely to move the stock significantly given the small dollar amount.
Market read
Primary insider purchase filing; limited trading relevance due to small size.
What to watch
Potential upcoming clinical data releases could amplify the significance of insider activity.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Form 4 shows CEO Edell Michael bought 2,000 shares at $0.6444, a $1.3K purchase increasing his stake to 11,000 shares.
potential modest upside as market prices in insider buying
Small but direct purchase by CEO; size is limited, so impact likely limited to short‑term sentiment.
Market effects
Minimal; the transaction does not affect the broader biotech sector.
None; the filing is U.S. SEC‑based with no regional spillover.
Low; only relevant to investors in SNES.
Counterpoint
The purchase is too small to outweigh other fundamentals; investors should focus on pipeline progress.
Key entities
- companySenesTech, Inc.
Biotech firm (ticker SNES) whose CEO made the purchase.
- personEdell Michael
Chief Executive Officer of SenesTech, Inc.